Definitive Healthcare Corp. Class A (DH)

The past six months have seen several events impacting Definitive Healthcare's stock price. As of March 18, 2026, the stock price was $1.07 per share, a significant decline from March 19, 2025. Key events include Q4 2025 earnings with a 1% year-over-year revenue decline but exceeding guidance, Q3 2025 earnings with a 4% revenue decrease, and Q2 2025 earnings with a 5% revenue decline. Several analysts lowered their price targets for DH.

Direct information on the demand seasonality for Definitive Healthcare's specific products and services is not explicitly detailed. The broader healthcare business intelligence market is experiencing significant growth. Historical stock performance shows some seasonality, with June historically being the strongest month and February tending to be the weakest. The company's revenue has shown some quarterly fluctuations, but these are not explicitly attributed to seasonal demand patterns.

Definitive Healthcare Corp. is a leading provider of healthcare commercial intelligence, offering a SaaS platform that provides comprehensive information on the healthcare ecosystem. The company transforms data, analytics, and expertise into actionable healthcare commercial intelligence, helping customers optimize operations. The platform features 16 intelligence modules covering various functional areas. Major products and solutions include the View Suite, Atlas Dataset, Population Intelligence, Monocl Expert Suite, Populi Suite, Carevoyance, and Market Forecast.

Definitive Healthcare Corp. provides its SaaS healthcare commercial intelligence platform in the United States and internationally. The company derives substantially all of its revenue from subscription fees, with a majority coming from the United States.

Definitive Healthcare's brand reputation in the past year has been mixed. Positive aspects include product innovation, valuable data, easy contact sourcing, and improved retention trends. Negative feedback includes poor customer service, uncreative solutions, contract issues, and declining customer retention.

Definitive Healthcare Corp. has a mixed ownership structure comprising institutional, insider, and retail investors. As of March 20, 2026, there were 160 institutional owners holding a total of 90,882,995 shares. Major institutional owners include Advent International Corp/ma, Goldman Sachs Group Inc, and BlackRock, Inc. Key individual owners and insiders include David Mussafer, Jason Krantz, and Kevin Coop. Approximately 11.85% of the company's stock is owned by institutional investors, 9.11% by insiders, and 79.04% by public companies and individual investors.